Insider trade

Pfizer (PFE): Director bought ~$28K

Scott Gottlieb, Director at Pfizer, bought ~$28K of Pfizer shares.

~$28K
Approx. value · 1,000 sh @ $28.24
10K
Holds after · shares reported
Traded
Oct 30, 2024
Filed
Oct 31, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 9, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  2. Sep 12, 2024FDAFDA drug approval: Mektovi
  3. Sep 12, 2024FDAFDA drug approval: Braftovi
  4. Oct 11, 2024FDAFDA drug approval: Hympavzi
  5. Oct 15, 2024FDAFDA drug approval: Fragmin
  6. Oct 15, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  7. Oct 21, 2024CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
  8. Oct 30, 2024 · this disclosureInsiderDirector purchased ~$28K of PFE shares in the open market

What came next

  1. Dec 20, 2024FDAFDA drug approval: Braftovi
  2. Dec 20, 2024Layoff notice · Heights Union East, 2002 N. 6th Floor, TAMPA, FL, 33602Layoff notice filed in FL: 62 employees
  3. Jan 15, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  4. Jan 24, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  5. Jan 31, 2025FDAFDA drug approval: Paxlovid (Copackaged)
  6. Feb 13, 2025InsiderDirector purchased ~$499K of PFE shares in the open market
  7. Feb 21, 2025FDAFDA drug approval: Xeljanz
  8. Feb 21, 2025FDAFDA drug approval: Xeljanz XR
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Pfizer

OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Scott Gottlieb, Director

The full history of Scott Gottlieb, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data